Literature DB >> 19440739

Covalent complexes of proteasome model with peptide aldehyde inhibitors MG132 and MG101: docking and molecular dynamics study.

Siwei Zhang1, Yawei Shi, Hongwei Jin, Zhenming Liu, Liangren Zhang, Lihe Zhang.   

Abstract

20S proteasome plays a critical role in the regulation of several important cellular processes and has drawn extensive interest in the field of anti-tumor research. Peptide aldehydes can inhibit the 20S proteasome activity by covalently binding to the active site of the beta subunits. In this work, covalent docking in conjunction with molecular dynamics (MD) simulation was used to explore the binding mode of MG132. Two conformations with the lowest docking energy were selected as the representative binding modes. One of the conformations was confirmed as a more reasonable binding mode by molecular dynamics simulations. The binding mode analysis revealed that a space demanding aromatic group with a short linker at the P4 site of the peptide aldehyde inhibitor would form favorable hydrophobic contacts with the neighboring subunit. A bulky substituent at the P2 position would also increase the binding stability by reducing water accessibility of the covalent bond. This study contributed to our understanding of the mechanism and structure-activity relationship of the peptide aldehyde inhibitors and may provide useful information for rational drug design.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19440739     DOI: 10.1007/s00894-009-0515-0

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  29 in total

1.  The structure of the mammalian 20S proteasome at 2.75 A resolution.

Authors:  Masaki Unno; Tsunehiro Mizushima; Yukio Morimoto; Yoshikazu Tomisugi; Keiji Tanaka; Noritake Yasuoka; Tomitake Tsukihara
Journal:  Structure       Date:  2002-05       Impact factor: 5.006

2.  3D-QSAR studies on tripeptide aldehyde inhibitors of proteasome using CoMFA and CoMSIA methods.

Authors:  Yong-Qiang Zhu; Jian-Feng Pei; Zhen-Ming Liu; Lu-Hua Lai; Jing-Rong Cui; Run-Tao Li
Journal:  Bioorg Med Chem       Date:  2005-10-26       Impact factor: 3.641

3.  Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1.

Authors:  A K Nussbaum; T P Dick; W Keilholz; M Schirle; S Stevanović; K Dietz; W Heinemeyer; M Groll; D H Wolf; R Huber; H G Rammensee; H Schild
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

4.  Development and validation of a genetic algorithm for flexible docking.

Authors:  G Jones; P Willett; R C Glen; A R Leach; R Taylor
Journal:  J Mol Biol       Date:  1997-04-04       Impact factor: 5.469

5.  A multicatalytic protease complex from pituitary that forms enkephalin and enkephalin containing peptides.

Authors:  M Orlowski; S Wilk
Journal:  Biochem Biophys Res Commun       Date:  1981-08-14       Impact factor: 3.575

6.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

7.  Crystal structures of Salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of beta-lactone ring opening and a mechanism for irreversible binding.

Authors:  Michael Groll; Robert Huber; Barbara C M Potts
Journal:  J Am Chem Soc       Date:  2006-04-19       Impact factor: 15.419

8.  Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine.

Authors:  S Tsubuki; Y Saito; M Tomioka; H Ito; S Kawashima
Journal:  J Biochem       Date:  1996-03       Impact factor: 3.387

9.  Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids.

Authors:  J Adams; M Behnke; S Chen; A A Cruickshank; L R Dick; L Grenier; J M Klunder; Y T Ma; L Plamondon; R L Stein
Journal:  Bioorg Med Chem Lett       Date:  1998-02-17       Impact factor: 2.823

10.  3D-QSAR studies on fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors by CoMFA and CoMSIA.

Authors:  Juan Zeng; Guixia Liu; Yun Tang; Hualiang Jiang
Journal:  J Mol Model       Date:  2007-07-06       Impact factor: 1.810

View more
  10 in total

1.  Discovery of novel covalent proteasome inhibitors through a combination of pharmacophore screening, covalent docking, and molecular dynamics simulations.

Authors:  Aibo Li; Haopeng Sun; Lei Du; Xiaoxin Wu; Jianqin Cao; Qidong You; Yuyan Li
Journal:  J Mol Model       Date:  2014-11-14       Impact factor: 1.810

2.  Proteasome properties of hemocytes differ between the whiteleg shrimp Penaeus vannamei and the brown shrimp Crangon crangon (Crustacea, Decapoda).

Authors:  Sandra Götze; Reinhard Saborowski; Oliviert Martínez-Cruz; Adriana Muhlia-Almazán; Arturo Sánchez-Paz
Journal:  Cell Stress Chaperones       Date:  2017-06-23       Impact factor: 3.667

3.  Phage-Related Ribosomal Protease (Prp) of Staphylococcus aureus: In Vitro Michaelis-Menten Kinetics, Screening for Inhibitors, and Crystal Structure of a Covalent Inhibition Product Complex.

Authors:  Julia A Hotinger; Heather A Pendergrass; Darrell Peterson; H Tonie Wright; Aaron E May
Journal:  Biochemistry       Date:  2022-06-22       Impact factor: 3.321

4.  Potential drug discovery for COVID-19 treatment targeting Cathepsin L using a deep learning-based strategy.

Authors:  Wei-Li Yang; Qi Li; Jing Sun; Sia Huat Tan; Yan-Hong Tang; Miao-Miao Zhao; Yu-Yang Li; Xi Cao; Jin-Cun Zhao; Jin-Kui Yang
Journal:  Comput Struct Biotechnol J       Date:  2022-05-17       Impact factor: 6.155

5.  ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors.

Authors:  Marianna Halasi; Ming Wang; Tanmay S Chavan; Vadim Gaponenko; Nissim Hay; Andrei L Gartel
Journal:  Biochem J       Date:  2013-09-01       Impact factor: 3.857

6.  Crystal structure of N-{N-[N-acetyl-(S)-leuc-yl]-(S)-leuc-yl}norleucinal (ALLN), an inhibitor of proteasome.

Authors:  Andrzej Czerwinski; Channa Basava; Miroslawa Dauter; Zbigniew Dauter
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-02-07

7.  Virtual screening using covalent docking to find activators for G245S mutant p53.

Authors:  Sara Ibrahim Omar; Marco Gaetano Lepre; Umberto Morbiducci; Marco Agostino Deriu; Jack A Tuszynski
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

Review 8.  Theory and applications of covalent docking in drug discovery: merits and pitfalls.

Authors:  Hezekiel Mathambo Kumalo; Soumendranath Bhakat; Mahmoud E S Soliman
Journal:  Molecules       Date:  2015-01-27       Impact factor: 4.411

Review 9.  Computational Approaches for the Discovery of Human Proteasome Inhibitors: An Overview.

Authors:  Romina A Guedes; Patrícia Serra; Jorge A R Salvador; Rita C Guedes
Journal:  Molecules       Date:  2016-07-16       Impact factor: 4.411

Review 10.  Advances in covalent drug discovery.

Authors:  Lydia Boike; Nathaniel J Henning; Daniel K Nomura
Journal:  Nat Rev Drug Discov       Date:  2022-08-25       Impact factor: 112.288

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.